Discover
OACC
Oaktree Acquisition Corp. III Life Sciences
10.70
3 x 10.63
4 x 10.64
bid
ask
+
0.00
0.00%
4 @ 04:00 PM
10.71 +0.01 (0.09%)
| Ytd | 1.13% | |
| 1y | 2.29% |
10.70
day range
10.70
10.30
52 week range
10.74
| Open | 10.70 | Prev Close | 10.70 | Low | 10.70 | High | 10.70 | Mkt Cap | 263.04M |
| Vol | 28.00 | Avg Vol | 14.07K | EPS | 0.29 | P/E | 36.90 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-01 | 50-d Avg | 10.66 | 200-d Avg | 10.62 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 456.54K | ||
| Selling, General and Administrative Expense | 456.54K | ||
| Operating Income | -456.54K | ||
| Net Income | 1.39M | ||
| Net Income Common Stock | 1.39M | ||
| Net Income Common Stock (USD) | 1.39M | ||
| Consolidated Income | 1.39M | ||
| Earnings per Basic Share | 0.06 | ||
| Earnings per Basic Share (USD) | 0.06 | ||
| Earnings per Diluted Share | 0.06 | ||
| Earning Before Interest & Taxes (EBIT) | 1.39M | ||
| Earning Before Interest & Taxes (USD) | 1.39M | ||
| Weighted Average Shares | 24.58M | ||
| Weighted Average Shares Diluted | 24.58M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.28M | ||
| Cash and Equivalents (USD) | 1.28M | ||
| Investments | 203.41M | ||
| Investments Non-Current | 203.41M | ||
| Current Assets | 1.42M | ||
| Total Assets | 204.83M | ||
| Debt Current | 11.82K | ||
| Total Debt | 11.82K | ||
| Current Liabilities | 1.62M | ||
| Total Liabilities | 8.64M | ||
| Accumulated Retained Earnings (Deficit) | -7.23M | ||
| Shareholders Equity | -7.23M | ||
| Shareholders Equity (USD) | -7.23M | ||
| Assets Non-Current | 203.41M | ||
| Total Debt (USD) | 11.82K | ||
| Liabilities Non-Current | 7.02M | ||
| Trade and Non-Trade Payables | 1.61M | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -158.03K | ||
| Net Cash Flow from Operations | -158.03K | ||